Blepharoptosis

Blepharoptosis (ptosis) is an abnormally low position of the upper eyelid margin relative to its normal resting position, which in primary gaze typically sits just below the superior corneal limbus. Ptosis can be congenital or acquired, and while many cases are benign and slowly progressive, ptosis can also be the presenting sign of serious neurologic or neuromuscular disease — making accurate categorization by mechanism a clinical priority rather than a purely cosmetic concern. Acquired ptosis becomes more common with age, most often from age-related stretching or dehiscence of the levator aponeurosis.¹ It can also arise iatrogenically, after periocular procedures, botulinum neurotoxin injection, or as a complication of prior blepharoplasty (overcorrection causing retraction, or undercorrection leaving residual ptosis).¹⁴ Congenital ptosis most often results from a localized dystrophy of the levator palpebrae superioris rather than a systemic process.³

Ptosis results from dysfunction anywhere along the eyelid-elevation pathway: the levator palpebrae superioris (CN III) and its aponeurosis, the sympathetically-innervated Müller's muscle, or the neuromuscular junction and upper motor neuron pathways. Categories: aponeurotic (stretching/dehiscence of the levator aponeurosis, most common acquired cause, generally preserved levator function), myogenic (primary muscle/neuromuscular junction dysfunction — congenital dystrophy, myasthenia gravis, other myopathies), neurogenic (CN III palsy or Horner syndrome affecting Müller's muscle), mechanical (a mass or excess tissue weight restricting elevation), and traumatic/iatrogenic (direct injury to the levator or aponeurosis).

Patients report a droopy eyelid, superior visual field restriction, or a compensatory chin-up/frontalis-overaction posture. Acquired ptosis that varies through the day, worsens with fatigue, or accompanies other muscle weakness should raise concern for myasthenia gravis.

Because ptosis is a sign rather than a single diagnosis, the differential is a differential of cause: myasthenia gravis (workup extends to antibody testing, electrophysiology, and thymoma screening in all confirmed cases)², Horner syndrome (ptosis, miosis, anhidrosis), CN III palsy (ptosis with ophthalmoplegia ± pupil involvement — pupil involvement suggests a compressive lesion requiring urgent neuroimaging), congenital myasthenic syndromes and other cranial neuropathies (important to distinguish from acquired MG)², simple dermatochalasis mimicking true ptosis, and contralateral eyelid retraction creating a false appearance of ptosis on the normal side.

Margin reflex distance 1 (MRD1) — the distance from the corneal light reflex to the upper lid margin, normally about 4-5 mm — is the standard quantitative severity measure.¹ Levator function is measured as lid excursion from downgaze to upgaze with the frontalis immobilized; poor function (roughly under 4-5 mm) indicates more severe dysfunction and changes the surgical approach.³ Standardized photography documents baseline asymmetry and tracks treatment response.¹ Pupil size and reactivity must be assessed in any new ptosis, since anisocoria raises concern for Horner syndrome or CN III palsy. Fatigability with sustained upgaze or improvement with an ice-pack test supports myasthenia gravis.²

Management depends entirely on mechanism and severity. Nonsurgical options for select mild acquired ptosis include topical oxymetazoline 0.1%, with randomized-trial evidence for modest MRD1 and visual field improvement, and off-label adrenergic agents; targeted pretarsal botulinum toxin has been described as an adjunctive option, though supporting evidence for this specific approach remains limited.¹ Surgical repair is guided primarily by levator function: aponeurotic repair or levator resection/advancement for good function, and frontalis muscle suspension or advancement for severe congenital ptosis with poor levator function — though a review found continued variability in surgical standardization across published series, with no single approach definitively established as superior.³ Surgical overcorrection (iatrogenic upper eyelid retraction) is correctable with a graduated approach: releasing the pretarsal cicatrix or levator aponeurosis, then recessing, then if needed lengthening the levator-Müller's muscle complex, achieving good or fair symmetry in the large majority of treated eyelids in one series.⁴

• MRD1 and levator function are the two measurements that most directly guide both diagnosis and surgical planning^1,3
• New ptosis with anisocoria is a red flag requiring immediate distinction between Horner syndrome and CN III palsy, the latter requiring urgent neuroimaging if the pupil is involved
• Fatigability or variability through the day should prompt myasthenia gravis workup including chest imaging for thymoma screening in every confirmed case²
• Topical oxymetazoline has randomized-trial-level evidence for modest benefit in select acquired ptosis¹
• Common pitfall: treating ptosis as purely cosmetic without assessing pupil size/reactivity and levator function
• Common pitfall: assuming all nonsurgical options have equivalent evidentiary support — botulinum toxin specifically has more limited data¹
• Common pitfall: failing to recognize surgical overcorrection as a distinct, separately manageable complication⁴